Global Gastric Cancer Market Analysis 2016 - Forecast to 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Gastric Cancer Market Analysis 2016 - Forecast to 2022" report to their offering.

This report analyzes the global markets for "Gastric Cancer". The market assessment is performed through standard and the tailored research methodology approach.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Gastric Cancer Market by Testing Type

  • Chest X-Ray
  • Computed Tomography (CT or CAT) Scan
  • Helicobacer Pylori
  • Imaging Tests
  • Laparoscopy
  • Magnetic Resonance Imaging (MRI) Scan
  • Positron Emission Tomography (PET) Scan
  • Upper Gastrointestinal (GI) Series

6 Gastric Cancer Market by Drug Class

  • Docetaxel
  • Doxorubicin Hydrochloride
  • Fluorouracil
  • Imatinib
  • Mitomycin C
  • Sunitinib
  • Trastuzumab

7 Gastric Cancer Market by Treatment Type

  • Adjuvant chemotherapy
  • Chemo Therapy
  • Radiation therapy
  • Surgery
  • Targeted drugs therapy

8 Gastric Cancer Market by Geography

9 Vendor Landscaping

10 Company Profiles

10.1 Eli Lilly and Company

10.2 AstraZeneca Plc.

10.3 Biogen idec

10.4 Bristol Myers Squibb

10.5 F Hoffmann-La Roche

10.6 Genentech, Inc

10.7 GlaxoSmithKline

10.8 Hoffmann-la Roche inc.

10.9 Immunogen

10.10 Merck KGaA

10.11 Novartis AG

10.12 Oncolytics

10.13 Otsuka Pharmaceutical

10.14 Pacific edge diagnostics NZ

10.15 Roche Holdings AG

10.16 Sanofi-Aventis

10.17 Zova biotherapeutics Inc.

10 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/mwjzz6/global_gastric

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs